Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients.
The efficacy and safety of cyclosporin A (CyA) for patients with rheumatoid arthritis were assessed in a four month double blind, placebo controlled study using an initial dosage of 5 mg/kg daily. Six patients withdrew from the study (two in the placebo group because of inefficacy of treatment and f...
Guardat en:
| Publicat a: | Ann Rheum Dis |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
1988
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1003464/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3281603/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.47.2.127 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|